Government & Legislative Affairs

AdvaMed® Statement on the PREEMIE Act

Today, AdvaMed® President and CEO Scott Whitaker released the following statement upon House passage of The Prematurity Research Expansion and Education for Mothers who deliver Infants Early (PREEMIE) Reauthorization Act: